CORC

在结果中检索

CORC

浏览/检索结果: 共68条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
The Interim Efficacy of Epigenetic Priming Regimen with Azacytidine and Chidamide in Patients with Relapsed or Refractory Peripheral T Cell Lymphoma 期刊论文
BLOOD, 2021, 卷号: 138
作者:  Ding, Kaiyang;  Shi, Xiao;  Yang, Haiyan;  Cao, Lei;  Zhao, Xiaoli
收藏  |  浏览/下载：8/0  |  提交时间：2022/12/23
Pharmacodynamic, pharmacokinetic, and phase 1a study of bisthianostat, a novel histone deacetylase inhibitor, for the treatment of relapsed or refractory multiple myeloma 期刊论文
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 9
作者:  Zhou, Yu-bo;  Zhang, Yang-ming;  Huang, Hong-hui;  Shen, Li-jing;  Han, Xiao-feng
收藏  |  浏览/下载：92/0  |  提交时间：2021/11/04
Chidamide, a novel histone deacetylase inhibitor inhibits multiple myeloma cells proliferation through succinate dehydrogenase subunit A 期刊论文
AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 卷号: 9, 期号: 3
作者:  Sun, Yifeng;  Li, Jing;  Xu, Zhao;  Xu, Jiadai;  Shi, Miaojie
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
Progressive diffuse large B-cell lymphoma with TP53 gene mutation treated with chidamide-based chemotherapy. 期刊论文
Immunotherapy, 2019
作者:  Li Qing;  Huang Jingcao;  Ou Yang;  Li Yan;  Wu Yu
收藏  |  浏览/下载：32/0  |  提交时间：2019/02/25
miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation 期刊论文
BIOMEDICINE & PHARMACOTHERAPY, 2019, 卷号: 119
作者:  Huang, Tao;  Fu, Yue;  Wang, Siqi;  Xu, Man;  Yin, Xiaolin
收藏  |  浏览/下载：15/0  |  提交时间：2019/12/11
Low-dose chidamide restores immune tolerance in ITP in mice and humans 期刊论文
BLOOD, 2019, 卷号: 133, 期号: 7, 页码: 730-742
作者:  Zhao, Hong-yu;  Ma, Ya-hui;  Li, Da-qi;  Sun, Tao;  Li, Li-zhen
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/11
The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF‑κB pathway in multiple myeloma cells 期刊论文
International Journal of Molecular Medicine, 2019, 卷号: Vol.43 No.1, 页码: 285-293
作者:  Zhaoyun Liu;  Qian Jing;  Yangyang Wang;  Yanqi Li;  Fu Mi
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/13
The short-term effect of histone deacetylase inhibitors, chidamide and valproic acid, on the NF-B pathway in multiple myeloma cells 期刊论文
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 卷号: Vol.43 No.1, 页码: 285-293
作者:  Liu, Zhaoyun;  Jing, Qian;  Wang, Yangyang;  Li, Yanqi;  Mi, Fu
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/17
Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC 期刊论文
2019, 卷号: 10, 期号: 5, 页码: 1275-1287
作者:  Zhang, Ningning;  Liang, Caixia;  Song, Wenya;  Tao, Dan;  Yao, Jiarui
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Circulating PD-1 (+) cells may participate in immune evasion in peripheral T-cell lymphoma and chidamide enhance antitumor activity of PD-1 (+) cells 期刊论文
2019, 卷号: 8, 期号: 5, 页码: 2104-2113
作者:  Zhang, Wei;  Shen, Haorui;  Zhang, Yan;  Wang, Wei;  Hu, Shaoxuan
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace